Position in YDES
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$37,622
+$6,952 QoQ
Shares Held
4,886
+94.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 8 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in YDES Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WOLVERINE ASSET MANAGEMENT LLC holds $4,246,654 across 11 Biotechnology names. YDES ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
125,265 | $1,811,331 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
22,815 | $1,713,178 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,322 | $249,924 | |
| 4 | DAWN |
Day One Biopharmaceuticals, Inc.
|
9,500 | $203,680 | |
| 5 | SRPT |
Sarepta Therapeutics, Inc.
|
4,920 | $107,059 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
1,521 | $72,353 | |
| 7 | OABIW |
OmniAb, Inc.
|
27,325 | $42,900 | |
| 8 | YDES |
YD Bio Ltd
This page
|
4,886 | $37,622 |
All Filings in YDES
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,622 | 4,886 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $30,670 | 2,516 | Shares | Defined | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||